ChickenStockChickenStock

AI English summary of an SEC filing — figures as filed

HCA Healthcare logoHCA Healthcare HCA

HCA Healthcare said on February 24, 2026 the Compensation Committee of its Board of Directors adopted the 2026 Executive Officer Performance Excellence Program. Executive officers are eligible to earn performance awards based on the achievement of specified performance targets, with awards paid entirely in cash.

8-KDeparture or Appointment of Directors or Certain OfficersFiled Period of report Summary published (UTC)

Key points

AI summary
  1. HCA Healthcare said on February 24, 2026 the Compensation Committee of its Board of Directors adopted the 2026 Executive Officer Performance Excellence Program. Executive officers are eligible to earn performance awards based on the achievement of specified performance targets, with awards paid entirely in cash.

  2. The company said award opportunities under the program are weighted 80% for achievement of EBITDA targets and 20% for achievement of quality metric targets. The quality portion comprises Healthcare-Associated Infections and Sepsis at 30%, Complication and Mortality at 30%, and Care Experience at 40%.

  3. HCA Healthcare said target award opportunities for 2026 for its named executive officers are 175% of base salary for Chief Executive Officer Samuel N. Hazen; 125% of base salary for Michael A. Marks, Executive Vice President and Chief Financial Officer, and Jon M. Foster, Executive Vice President and Chief Operating Officer; and 100% of base salary for Michael R. McAlevey, Executive Vice President – Chief Legal and Administrative Officer, and Michael S. Cuffe, M.D., Executive Vice President and Chief Clinical Officer.

  4. The company said Robert J. Dennis informed it on February 20, 2026 that he would not stand for re-election and would retire from the Board of Directors effective at the annual meeting of stockholders on April 23, 2026.

Summary

AI-written

Analysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

2026 Executive Officer Performance Excellence Program Adopted

HCA Healthcare said on February 24, 2026 the Compensation Committee of its Board of Directors adopted the 2026 Executive Officer Performance Excellence Program. Executive officers are eligible to earn performance awards based on the achievement of specified performance targets, with awards paid entirely in cash.

Source · Based on the filing body and exhibits

EBITDA Weighting 80%; Quality Metrics Weighting 20%

The company said award opportunities under the program are weighted 80% for achievement of EBITDA targets and 20% for achievement of quality metric targets. The quality portion comprises Healthcare-Associated Infections and Sepsis at 30%, Complication and Mortality at 30%, and Care Experience at 40%.

Source · Based on the filing body and exhibits

Target Award Opportunities for 2026 by Named Executive Officer

HCA Healthcare said target award opportunities for 2026 for its named executive officers are 175% of base salary for Chief Executive Officer Samuel N. Hazen; 125% of base salary for Michael A. Marks, Executive Vice President and Chief Financial Officer, and Jon M. Foster, Executive Vice President and Chief Operating Officer; and 100% of base salary for Michael R. McAlevey, Executive Vice President – Chief Legal and Administrative Officer, and Michael S. Cuffe, M.D., Executive Vice President and Chief Clinical Officer.

Source · Based on the filing body and exhibits

Robert J. Dennis to Retire from Board

The company said Robert J. Dennis informed it on February 20, 2026 that he would not stand for re-election and would retire from the Board of Directors effective at the annual meeting of stockholders on April 23, 2026.

Source · Based on the filing body and exhibits

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.

Source: SEC EDGAR (U.S. Securities and Exchange Commission). Item captions are the SEC's. The summary is for reference only and is not investment advice.